A 36-year-old CEO saw how psychedelics treated his best friend’s mental illness. Now his Peter Thiel-funded firm wants to bring the drugs to the masses
Florian Brand knows that there aren’t many people with his profile in biopharma. “You would probably consider me an outlier,”...